1. Home
  2. Analysis
  3. Nitrostat
  4. Xeljanz-xr

Nitrostat and Xeljanz xr drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nitrostat and Xeljanz xr. Common interactions include atrial fibrillation among females and cough among males.

The phase IV clinical study analyzes what interactions people who take Nitrostat and Xeljanz xr have. It is created by eHealthMe based on reports of 23 people who take Nitrostat and Xeljanz xr from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 26, 2022

23 people who take Nitrostat and Xeljanz xr together, and have interactions are studied.

What is Nitrostat?

Nitrostat has active ingredients of nitroglycerin. It is often used in chest pain. eHealthMe is studying from 13,156 Nitrostat users for its effectiveness, alternative drugs and more.

What is Xeljanz xr?

Xeljanz xr has active ingredients of tofacitinib citrate. eHealthMe is studying from 82,349 Xeljanz xr users for its effectiveness, alternative drugs and more.

Number of Nitrostat and Xeljanz xr reports submitted per year:

Nitrostat and Xeljanz xr drug interactions.

Common Nitrostat and Xeljanz Xr drug interactions by gender *:

female:

  1. Atrial fibrillation
  2. Insomnia
  3. Lip blister
  4. Localised infection
  5. Pruritus
  6. Urticaria
  7. Oropharyngeal pain
  8. Pneumonia
  9. Urinary tract infection
  10. Cough

male:

  1. Cough
  2. Dyspnoea
  3. Adrenal insufficiency
  4. Anxiety
  5. Arteriosclerosis coronary artery
  6. Atrial fibrillation
  7. Bacterial infection
  8. Balance disorder
  9. Benign prostatic hyperplasia
  10. Cardiomyopathy

Common Nitrostat and Xeljanz Xr drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Pneumonia
  2. Cough
  3. Dyspnoea
  4. Musculoskeletal chest pain
  5. Oropharyngeal pain
  6. Respiratory rate decreased
  7. Urinary tract infection
  8. Immune system disorder
  9. Corneal perforation
  10. Depressed mood

Common conditions people have *:

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 18 people, 78.26%
  2. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 8.70%
  3. Cardiac Disorder: 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Nitrostat and Xeljanz xr?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Nitrostat and Xeljanz xr:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Nitrostat side effects:

Browse all side effects of Nitrostat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Xeljanz xr side effects:

Browse all side effects of Xeljanz xr:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Nitrostat interactions:

Browse all interactions between Nitrostat and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Xeljanz xr interactions:

Browse all interactions between Xeljanz xr and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on nitroglycerin and tofacitinib citrate (the active ingredients of Nitrostat and Xeljanz xr, respectively), and Nitrostat and Xeljanz xr (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Nitrostat and Xeljanz xr.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.